A new antibiotic is set to enter late-stage human trials for tackling the superbug Acinetobacter baumannii.
This drug is the first new class of antibiotics in decades and could potentially destroy drug-resistant bacteria that have an outer and inner membrane, making them harder to kill.
https://www.thetimes.com/uk/science/article/antibiotic-medicine-superbug-final-testing-sxjclpwp5